Team
An expert team of bioprocessing scientists and industry leaders who are deeply engaged in the scientific pursuit of growing a platform biotechnology company that enables next-generation biopharmaceutical manufacturing technologies to impact patients’ lives.

Kevin Isett, PhD
Chief Executive Officer, CoFounder
bio
Merck – 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D
Merck – Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies
Dartmouth College, Thayer Engineering School – Merck-Sponsored Doctoral Fellow

Warren Kett, PhD
Chief Scientific Officer, CoFounder
bio
Glycan Biosciences – Co-Founder and CTO
GlycoFi (Acquired by Merck in 2006) – Senior Chemist

Tillman Gerngross, PhD
Chairman of the Board, CoFounder
bio
Alector – Co-Founder and Chairman of the Board
Arsanis – Co-Founder and President
GlycoFi (Acquired by Merck in 2006) – Co-Founder and CSO
Dartmouth College – Professor of Bioengineering and Associate Provost of the Office of Entrepreneurship and Technology Transfer
SV Life Sciences – Venture Partner

Scott Kennedy
bio
PerkinElmer
McGladrey & Pullen
University of Minnesota

Kimberly Cornwell
bio
Outside GC
Sanofi Pasteur
Acambis
Edwards and Angell
Boston University School of Law

Karol Lacki, PhD
bio
Novo Nordisk A/S – Director Mathematical Modeling
GE Healthcare Life Sciences – Customer Collaboration Leader
Amersham Pharmacia Biotech – Polymer and Surface Chemistry

Grant Espie
bio
Dupont – Principal Investigator
EMD Chemicals Inc. – Technical Manager
Novasep Inc. – Engineering Manager

Nick Russell
Head of Business Development
bio
Pall Biotech (Acquired by Danaher Corporation)
Pfizer
University of Missouri

Brittany Crocco
Head of Quality
bio
Agilent Technologies – Nucleic Acid Solutions
Nitto Denko – Kinovate Life Sciences
University of the Sciences in Philadelphia
Certifications: ASQ, CMQ/OE, CQA
Tillman Gerngross, PhD
Co-Founder and Chairman of Avitide, Inc.
- Co-Founder and Chief Executive Officer, Adimab LLC
- Co-Founder and CSO, GlycoFi Inc. (acquired by Merck 2006)
- Co-Founder, Chairman of Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
- Co-Founder, Chairman of Avitide
- Co-Founder, Chairman of Alector (NASDAQ: ALEC)
- Professor of Bioengineering, Dartmouth College
- Venture Partner, SV Life Sciences
Kevin Isett, PhD
Co-Founder, CEO
- Head of High Throughput Manufacturing, Adimab
- 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D
- Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies
- Dartmouth College, Thayer Engineering School: Merck-Sponsored Doctoral Fellow
Phil Ferneau, MBA, J.D.
Board Director, Avitide Inc.
- Managing Director and Co-Founder, Borealis Ventures
- Board Director, Compass Therapeutics
- Board Director, Orbit Discovery Ltd.
- Founding Executive Director, Dartmouth’s Tuck School of Business Center for Private Equity and Entrepreneurship
- A.B. Dartmouth College
- J.D. University of Virginia School of Law
- M.B.A. Tuck School of Business at Dartmouth
Rishi Gupta, J.D.
Board Director, Avitide Inc.
- Partner, OrbiMed
- Board Director, EnLiven Therapeutics
- Board Director, Modis Therapeutics
- Board Director, NeuroPace
- Board Director, Pionyr Immunotherapeutics
- Board Director, Turnstone Biologics
- Board Director, Verona Pharma
- Healthcare Investment Banker, Raymond James & Associates
- Corporate Development Manager, Veritas Medicine
- A.B. Harvard College
- J.D. Yale Law School
Claudio Nessi, MBA, Ph.D.
Board Director, Avitide Inc.
- Managing Partner, NeoMed Management
- Managing Director, Omega Funds
- Board Director, Anaconda BioMed S.L.
- Board Director, GenKyoTex SA
- Board Director, Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
- Board Director, Axovan SA
- Board Director, Creabilis SA
- Board Director, Endosense SA
- Board Director, Kuros BioSurgery AG
- Board Director, PregLem SA
- M.B.A. Erasmus University
- Ph.D. University of Pavia
Ian Ratcliffe, MBA
Board Director, Avitide Inc.
- Managing Partner, Sands Capital Ventures
- Board Chairman & CEO, Asterand Biosciences Inc.
- Board Chairman & CEO, Enzymatics Inc.
- President. Upstate Biotechnology Inc.
- BEng. University of Surrey
- M.B.A. Darden School, University of Virginia
Ajay Royan
Board Director, Avitide Inc.
- Managing General Partner and Founder, Mithril Capital Management
- Board Director, Adimab LLC
- Board Director, AppDirect
- Board Director, Auris Health Inc.
- Board Director C2F0
- Managing Director, Clarium Capital Management
- Scientific Advisory Board Member, Oak Ridge National Laboratory
- B.A. Yale University